Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Coghlan

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Echo Research and Practice|June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UKNina Karia, Daniel Murphy, Luke Howard, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2021
Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatmentKarsten P Hug, J Gerry Coghlan, John Cannon, et al.
European Heart Journal|August 24, 2023
Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK studyNina Karia, Luke Howard, Martin Johnson, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|October 10, 2009
Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effectsLuigi P Badano, Carmen Ginghina, Jacob Easaw, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Annals of the Rheumatic Diseases|July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
Rheumatology (Oxford, England)|February 5, 2017
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosisLesley-Anne Bissell, Marina Anderson, Malcolm Burgess, et al.
European Heart Journal. Cardiovascular Imaging|August 19, 2024
Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertensionJames T Brown, Ruta Virsinskaite, Tushar Kotecha, et al.
Journal of Scleroderma and Related Disorders|June 24, 2024
Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologistsMaría Paula Álvarez-Hernández, Yannick Allanore, Ivo Andrade, et al.
JACC. Cardiovascular Imaging|February 18, 2019
Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary PhysiologyTushar Kotecha, Ana Martinez-Naharro, Michele Boldrini, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Echo Research and Practice|June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UKNina Karia, Daniel Murphy, Luke Howard, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2021
Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatmentKarsten P Hug, J Gerry Coghlan, John Cannon, et al.
European Heart Journal|August 24, 2023
Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK studyNina Karia, Luke Howard, Martin Johnson, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|October 10, 2009
Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effectsLuigi P Badano, Carmen Ginghina, Jacob Easaw, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Annals of the Rheumatic Diseases|July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
Rheumatology (Oxford, England)|February 5, 2017
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosisLesley-Anne Bissell, Marina Anderson, Malcolm Burgess, et al.
European Heart Journal. Cardiovascular Imaging|August 19, 2024
Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertensionJames T Brown, Ruta Virsinskaite, Tushar Kotecha, et al.
Journal of Scleroderma and Related Disorders|June 24, 2024
Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologistsMaría Paula Álvarez-Hernández, Yannick Allanore, Ivo Andrade, et al.
JACC. Cardiovascular Imaging|February 18, 2019
Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary PhysiologyTushar Kotecha, Ana Martinez-Naharro, Michele Boldrini, et al.
Pageof 11